TY  - GEN
AU  - Zamor,Philippe J
AU  - Vierling,John
AU  - Ghalib,Reem
AU  - Luketic,Velimir
AU  - Ravendhran,Natarajan
AU  - Balart,Luis
AU  - Robertson,Michael
AU  - Hwang,Peggy
AU  - Hanna,George J
AU  - Nguyen,Bach-Yen
AU  - Barr,Eliav
AU  - Talwani,Rohit
AU  - Pearlman,Brian
TI  - Elbasvir/grazoprevir in black adults with hepatitis C virus infection: a pooled analysis of phase 2/3 clinical trials
SN  - 1572-0241
PY  - 2019///0806
KW  - Adult
KW  - Black or African American
KW  - statistics & numerical data
KW  - Aged
KW  - Aged, 80 and over
KW  - Antiviral Agents
KW  - therapeutic use
KW  - Benzofurans
KW  - Clinical Trials, Phase II as Topic
KW  - Clinical Trials, Phase III as Topic
KW  - Drug Combinations
KW  - Drug Therapy, Combination
KW  - Female
KW  - Genotype
KW  - Hepacivirus
KW  - genetics
KW  - Hepatitis C, Chronic
KW  - drug therapy
KW  - Humans
KW  - Imidazoles
KW  - Male
KW  - Middle Aged
KW  - Quinoxalines
KW  - RNA, Viral
KW  - isolation & purification
KW  - Retrospective Studies
KW  - Ribavirin
KW  - Sustained Virologic Response
KW  - Treatment Failure
KW  - Young Adult
N1  - Publication Type: Evaluation Study; Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1038/s41395-018-0053-4
ER  -